Using RNA-seq, molecular assays, and behavioral analysis In Vitro and In Vivo, we showed that pharmacological inhibition of JNK signaling—particularly via JNK-IN-8—effectively suppresses CG cell death and alleviates cerebellar ataxia in a mouse model of MICPCH syndrome. Here, MAPK8 is linked to cerebellar ataxia.